LLY — Eli Lilly and Company (Stock)

Price: $1150.99 · 1 day: -1.64% · 5 days: +1.16% · 1 month: -7.69% · YTD: +7.10%
As of 2026-09-23 20:03 UTC.

52-week range: $712.05 – $1292.65 (currently at 76% of the range).

The read

LLY is in a turning up, momentum firm. $1176.62 is the level overhead; $1150 the first support below.

4 of 6 technical checks lean bullish.

Price vs 50-day: below
Price vs 200-day: above
50d vs 200d avg: above
MACD: bullish
RSI momentum: 46
5-day tape: +1.2%

Trend	Turning up · below 50-day & 200-day
Momentum	RSI 46.3 · neutral · MACD bullish
Trend strength	ADX 12.1 · weak or range
Location	-2.2% vs 50-day MA
52-week range	-10% from high · +61% from low
Volatility	ATR 27.75 · ~2.4%/day

Key levels

Level	Type	Distance
$1176.62 (resistance)	sma 50	2.23%
$1200.0 (resistance)	round	4.26%
$1250.0 (resistance)	round	8.6%
$1150.0 (support)	round	-0.09%
$1111.22 (support)	swing zone	-3.46%
$1100.0 (support)	round	-4.43%

Indicators

RSI (14)	46.3	MACD	-8.3912
ADX (14)	12.1	ATR (14)	27.75
50-day average	$1176.62	200-day average	$1068.31

Next earnings: 2026-10-29.

Latest LLY news

North American Morning Briefing: Futures Struggle; Oil Falls on Hope for Middle East Diplomacy — U.S. stock futures pointed to a higher open Tuesday, following the Nasdaq's first record close since June, though momentum appeared to fade. Oil prices reversed earlier gains after reports that Iran offered to reopen the (Morningstar, 2026-09-22)
S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University — S2S China, co-hosted by RA Capital Management and Qiming Venture Partners, has announced ten finalist biotech startup teams for its inaugural 2026 symposium. Selected from roughly 20 semifinalists after rigorous review, (PR Newswire, 2026-09-20)
S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University — S2S China, the inaugural China chapter of the Science2Startup symposium co-hosted by RA Capital Management and Qiming Venture Partners, has announced ten finalist biotech startup teams selected from a competitive applica (PR Newswire, 2026-09-20)
Novo investors call for dealmaking and new drugs — Novo shareholders are urging the Danish drugmaker to pursue acquisitions and develop new medicines to reduce its reliance on blockbuster weight-loss treatments, ahead of its investor day on Monday. The company, under CEO (Financial Times News, 2026-09-20)
Thatch Raises $108M at $1B Valuation as Employers Shift Away From Traditional Health Plans — Thatch, a health benefits platform enabling employers to shift from traditional group health plans to consumer-directed models, raised $108 million at a $1 billion valuation from leading investors including The General P (PR Newswire, 2026-09-15)
Here are Tuesday's biggest analyst calls: Nvidia, Apple, AMD, Etsy, Eli Lilly, Samsara & more — Tuesday's analyst calls featured a broad range of upgrades and initiations across sectors. Notable actions included Guggenheim upgrading The New York Times to buy with a $82 price target, Bernstein upgrading Agilon to ou (CNBC, 2026-09-15)
A Breakthrough Cancer Vaccine Fueled a Biotech Rally. Can It Last? - WSJ's Take On the Week - WSJ Podcasts — A breakthrough cancer vaccine development triggered a significant rally in biotech stocks, raising questions about the sustainability of the sector's momentum. The vaccine announcement represents a major clinical milesto (The Wall Street Journal, 2026-09-14)
Here are the 2 big things we're watching in this week's stock market — This week's stock market focus centers on the Federal Reserve's policy meeting, where market odds suggest a nearly 90% chance of an interest rate hike following August core CPI rising 0.3% month-over-month, slightly abov (CNBC, 2026-09-13)

Explore more

Interactive LLY chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs